PROVIDER PROFILE · NPI 1033325816
Melissa QuanDO
PRESCRIBING · PART D · 2024
Total Rx claims
922
Beneficiaries
—
Total drug cost
$65K
Distinct drugs
21
Brand share
25.9%
Top prescribed drugs
Gabapentin176 claims
Carbidopa/Levodopa111 claims
Levetiracetam106 claims
Duloxetine Hcl67 claims
Levetiracetam45 claims
QUALITY · MIPS · 2024
Final MIPS score
93.2
Quality
77.8
Cost
71.2
Improvement activities
40.0
Promoting interop.
98.0
Payment adjustment
0.77%
Group
CROSS-REFERENCE